… to report the benefit of a therapeutic approach consisting of … were refractory to all other
therapies, including subcutaneous … This method for treating cytokine storm should be considered …

… , which warrants the use of this therapy [Citation87]. However, there is a significant dilemma
regarding the use of anti-inflammatory therapy due to the criticality of their benefit/risk ratio. A …

… inhibition of IL-1, the sepsis-MAS subset may benefit. The COVID-19 pandemic dramatically
accelerated the pace at which anti-inflammatory therapies have been developed for treating …

… identify the patients who may benefit from an early escalation of the treatment [103]. … as
advanced age, immunocompromise and corticosteroid therapy, are responsible for a prolonged …

… potentially toxic therapies to individuals most likely to benefit. Whether work on this cytokine
is … question, as is establishing the ideal therapeutic window for treatment with type III IFNs …

… this Viewpoint, we use cytokine storm syndromes. Cytokine storm syndromes represent a key
… experience with immunosuppressive therapies and managing cytokine storm syndromes in …

… in the cytokine patterns, it seems that the cytokine storm plays … types of pro-inflammatory
cytokines and chemokines, which … called cytokine storm. Both local tissue inflammation and the …

… cytokine storm. This screening, when followed by aggressive early treatment for cytokine
storm, may have optimal therapeutic benefits … of the IL-6 receptor has profound benefits under …

… cytokine storm onset in COVID-19; these will benefit the understanding of artificial-liver support
system treatment for alleviating cytokine storm … as an anti-cytokine-storm targeted therapy, …

… A cytokine storm is life threatening for critically ill patients and is mainly caused by … therapy,
the cytokine adsorber Cytosorb ® (CS) is increasingly used for the treatment of cytokine storm…